See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.01▲ 0.54%
← 0NJ5 page
XStocksXray
Market X-Ray report · 22 October 2026

Safilo Group (0NJ5)

London Exchange · UK · prices in EUR · close of 22 Oct 2026

Key indicators

Last closeEUR 1.938
52-week range1.170 – 2.234
Return, 1 month / 3 months+10.1% / +10.4%
Return, 1 year / 3 years+6.0% / +163.6%
TrendUptrend
RSI (14)65
Volatility (1 year)45.1%
Worst drawdown (1 year)-31.0%
Average daily value traded0.02M EUR
Dividend yield–

Market X-Ray price-based

48/ 100 · High confidence · ahead of 42% of stocks on this exchange
Trend63
Momentum63
Stability (higher is calmer)40
Liquidity11
Income–

Five-year price chart navy: price · brown: 200-day average

0.581.011.451.882.312021-102023-022024-102025-122026-10

About the company

Safilo Group designs, manufactures and distributes eyewear, including prescription frames, sunglasses and sports and protective glasses. The Italian company makes frames under licence for fashion and luxury labels as well as under its own house brands, and it also produces lenses and optical components. Its customers are opticians, optical retail chains and other distributors, and its products reach consumers in markets across Europe, the Americas and Asia from its base in Padua.

On this site Safilo Group appears as a stock on the London Exchange (UK), code 0NJ5, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Safilo Group (0NJ5) trades on the London Exchange in UK. It last closed at EUR 1.938 on 22 October 2026.

Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,188 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 6.0% and over the last three months it rose 10.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Safilo Group (0NJ5)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend63 · FairMixed trend against its averages.
Above 200-day average7.8%
From 52-week high-12.7%
Momentum63 · FairTypical recent returns for this exchange.
3-month return10.4%
6-month return10.2%
12-month return, skipping the last month-3.7%
Stability (higher is calmer)40 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)45.1%
Worst drawdown, 1 year (smaller is calmer)-31.0%
Liquidity11 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.02M EUR
Zero-volume days45.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+0.6%
1 month+10.1%
3 months+10.4%
6 months+10.2%
1 year+6.0%
3 years+163.6%
5 years+38.0%

Signals

50-day / 200-day average1.836 / 1.797
Golden / death cross (60 days)Golden, 33 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.252

Technical summary

DailyStrongly bullish13 bullish · 1 neutral · 2 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026